Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
To successfully manage an Acute Bacterial Skin and Skin Structure Infection (ABSSSI) study, Pharm-Olam provided a complete enrollment solution for the management and data submission of this multi-region study. With the increase of ABSSSI diagnoses and ABSSSI-related hospitalizations, inconsistent treatment methods for those diagnosed, and resistance to previous standards of care makes this an important study for those in need.
We delivered a total of 380 patients for this particular study within 9 months, which allowed for the study to be completed 2 months ahead of time.
Click on the image to see read the complete case study on this Phase III ABSSSI trial.